Viewing Study NCT00541866

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:06 PM
Ignite Modification Date: 2026-02-22 @ 9:04 AM
Study NCT ID: NCT00541866
Status: COMPLETED
Last Update Posted: 2018-01-09
First Post: 2007-10-08
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans
Sponsor: Sunesis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leukemia View
None Acute Myeloid View
None Relapsed View
None Refractory View
None Cancer View
None AML View
None Cytarabine View
None SNS-595 View
None Phase 1 View
None Voreloxin View